This compounded preparation: Has not been approved by the FDA Has not undergone FDA review for safety, effectiveness, or quality Is prepared specifically for you based on your prescriber's order Individual outcomes may vary Dosing is determined by the prescribing provider based on patient-specific factors
GIP receptor activation adds something unique
These include: Lifestyle interventions (dietary advice, physical activity programmes) Licensed pharmacotherapy such as orlistat, or GLP-1 receptor agonists including semaglutide 2.4 mg (Wegovy, NICE TA875) or tirzepatide (Zepbound) where clinically indicated and available Referral to tier 3 or tier 4 weight management services , including bariatric surgery assessment where appropriate Information on NHS weight management services and eligibility for licensed treatments is available via the NHS website and NICE guidance
AOD 9604 vs other fat loss peptides You're probably considering other options
For long-term treatment, incorporating B vitamins into the feed using swine vitamin premix or top-dressing with supplements like Show Bloom is an option, though direct administration remains the most reliable method

Price includes: 1:1 doctor consult, unlimited messaging and support, written prescription + medicine and free shipping See if this is right for you B12 / MIC Boosts energy and metabolism Supports fat burn and lean muscle Breaks through weight loss plateaus See if this is right for you B12 Injection Helps reduce fatigue and support steady energy levels Aids in maintaining focus, memory, and overall brain health Supports red blood cell production and oxygen delivery See if this is right for you Lipo C Complex Burns fat more efficiently Boosts energy naturally Supports liver detox Enhances metabolism See if this is right for you Compounded Liraglutide Highly effective weight support Curbs appetite and sugar levels Once-daily subcutaneous injection See if this is right for you Personalized Compounded Tirzepatide Support weight loss and metabolic health by engaging GLP-1 and GIP pathways that regulate appetite